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Non-obstetrical surgery during the first trimester is stressful to both the mother and the fetus. Anesthesiologists 
are also stressed, not only because of the effects of surgery itself, but also because of the uncertain influences of 
anesthesia thrown upon on the fetus. The authors present a case of breast surgery successfully performed on a 
woman 8 weeks pregnant requiring removal of breast abscess by the application of thoracic paravertebral block 
without any complications. Thoracic paravertebral block may be a safe anesthetic method for non-obstetric surgery 
during early pregnancy. (Korean J Anesthesiol 2010; 59: S73-S76)
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    When preoperative pregnancy test are performed on child-
bearing aged women, 0.3-1.2% are shown to be positive [1]. 
Cases requiring non-obstetrical surgery during pregnancy is 
approximately 0.12% [2] and thus very low. However, when 
surgery is required, it becomes very stressful not only to the 
child bearer but also to the clinician. Anesthesia may cause 
physiological changes in the mother inducing teratogenic 
effects and fetal asphyxia, preterm labor, etc, to the fetus. It 
has been reported that the possibility of inducing deformity by 
clinically used anesthetics is almost nil; nonetheless, in cases 
undergoing surgery within 8 weeks of pregnancy, physiological 
changes of the mother caused by surgery and anesthesia may 
induce deformity, due to fetal organogenesis during that period. 
It is reported that if surgery is required during pregnancy, it 
is better to postpone it until the 2nd trimester if possible and 
preferably, perform regional anesthesia rather than general 
anesthesia [3].
    The authors present a case of breast surgery successfully 
performed on a woman 8 weeks pregnant requiring removal of 
breast abscess by the application of thoracic paravertebral block 
(TPVB) without any complications. 
Case Report 
    A 29-year-old female was under follow up observation at 
a local clinic for a mass in her left breast palpated 6 months 
prior to admission. Mass size increased due to pregnancy and 
showed inflammatory findings. She was thus transferred to our S74 www.ekja.org
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hospital for surgical treatment. Gestational age on admission 
was 8 weeks. In her presurgical breast ultrasonography, in 
the area 4 cm from the ten o’clock direction of the left nipple 
an approximately 4 × 3 cm sized mass without any distinct 
boundaries thought to be an abscess was detected. In her 
past medical history, specific findings were denied and 
undetected. The mass was deeply located close to the fascia 
of the pectoralis muscle, thus difficult to operate by local 
anesthesia. Pretreatments were not given. In the operating 
room, it was decided that TPVB be performed because it would 
affect the fetus less than general anesthesia. The consent 
of the patient was obtained after through explanation of 
the anesthetic method. Basic monitoring equipments were 
attached to the patient. Initial blood pressure was 120/70 
mmHg and pulse rate 82 beats per minute. Other specific 
findings were undetected. The patient took a sitting position 
with an assistant was positioned in front of her. She was asked 
to lower her head and lean against the chest of the assistant. 
After marking the C7 spinous process (SP) to the T1 SP with a 
skin marker, each mark of the T1 SP to the T5 SP was marked 
again horizontally 2.5 cm left of the initial mark. After marking 
the areas, her skin was prepared with povidone iodide solution 
and subsequently, 1.5 ml of 2% lidocaine was injected into each 
marked point subcutaneously. Afterwards, using five 20 gauge 
Tuohy needles, the skin of each point was pricked vertically. If 
the tip of the needle touched the transverse process, the needle 
was retreated and advanced by changing directions toward 
the head. The paravertebral space was assessed through a loss 
of resistance technique, and then the site was fixed. Each of 
the needles was installed in the marked site from the T1 SP to 
the T5 SP where a total of 20 ml of 0.5% ropiacaine, 4 ml each, 
was injected. The needles were then removed (Fig. 1). Sterile 
dressing was performed on all areas injected with the drug. 
The patient then took the supine position, and blood pressure 
and pulse rate were 100/55 mmHg and 100, respectively. Other 
specific findings were undetected and the patient did not 
portray any particular symptoms. The blockage range evaluated 
by an ice test of the area from T1 to T10. During surgery, the 
patient presented with severe anxiety and requested to be put 
asleep, and so propofol (Fresofol
Ⓡ, Fresenius Kabi, Austria), a 
pregnancy risk category B drug, was injected using a syringe 
pump (Pilote anesthesie IS, Fresenius vial S.A, France) at the 
rate of 90 μg/kg/min. Total anesthesia time was 60 minutes and 
the total operation time was 40 minutes. After surgery, she was 
transferred to a recovery room for 45 minutes in order to detect 
any pain or other special findings she might experience. After 
transferring to a ward, where she also did not experience any 
pain, further analgesics were not administered. 
    In the ultrasonography performed the day after surgery, 
fetal heart beat was 180 bpm, and gestational age measured by 
crown-to-rump length was 8 weeks +5 days. The patient was 
treated with cefotiam 1 g/day through intravenous infusion for 
4 days and was discharged without any complications. 
Discussion
    In cases performing surgery for non-obstetrical problems 
during pregnancy, maternal death, miscarriages, elective 
termination, and delivery induced by surgical procedure may 
be induced. For the fetus, fetal death, prematurity, and major 
birth defects may be induced. Particularly in cases undergoing 
surgery during the 1st trimester, the incidence of major 
malformation has been reported to be approximately 3.9%. 
Maternal death rate is very low. However, during the entire 
pregnancy, the incidence of miscarriage or fetal death has 
been reported to be 5.8%, and the risk raised to 10.5% during 
the 1st trimester. It has been reported that cases of selective 
termination due to anxiety of the birth of deformed babies were 
approximately 1.3% [4].
    In cases which the patient must receive surgery unavoidably, 
safety of the mother and the fetus associated with anesthesia 
and surgery becomes an important issue. According to the 
standard labeling of drugs used in pregnancy which was 
organized in 1979, they are classified in 5 categories. Based 
on the research data conducted on animals and humans, the 
Food and Drug Administration classifies them as follows: l A, 
Controlled studies have shown no risk; l B, No evidence of risk 
found in human beings; l C, A risk cannot be ruled out; l D, 
Positive evidence of risk exists; l X, The drug is contraindicated 
in pregnancy [5]. In animal experiments, nitrous oxide 
induces resorption and anomaly of the fetus [6]. In another 
Fig. 1. After inserting 20 gauge Tuohy needles into each level, from 
T1-T5, 0.5% ropivacaine was injected.S75 www.ekja.org
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experiments, inhalation anesthesia excluding nitrous oxide 
did not exert teratogenic effects. Studies reported that in 
humans exposed to sevoflurane at 0.2 ppm concentration for 
8 hours, sister chromatid exchange occurred more than in 
cases without exposure by 30% [7]. Intravenous anesthetics 
like meperidine, propofol, and ketamine belong to category B. 
Fentanyl has been reported to lack teratogenicity; nonetheless, 
it exerts embryocidal effects and is classified as category C. It 
is reported that diazepam rapidly penetrates the placenta and 
accumulates in the fetus, and exposure to it during pregnancy is 
associated with cleft palate. Different from diazepam, however, 
midazolam has been reported to lack teratogenicity but their 
pharmacological reaction is similar with diazepam and thus 
classified as category D and not recommended during the 1st 
trimester [8]. Drugs that can be used safely during pregnancy is 
limited. A prospectively controlled study cannot be conducted 
on humans due to ethical issues, and so it is indeed impossible 
to assess drug effects on the human fetus.
    Regional anesthesia (RA) is safer than general anesthesia 
[2,3]. In regional anesthesia, less systemic absorption of 
drugs occur than general anesthesia and local anesthetics is 
classified as category B [5]. Thus, if surgical area or methods 
are appropriate, regional anesthesia can be performed safely. 
Nevertheless, during RA, rapid hemodynamic changes caused 
by sympathetic block may induce adverse effects on the fetus, 
and so appropriate precautions must be taken.
    RA performed during breast surgery include thoracic epidural 
block (TEB), thoracic paravertebral block (TPVB), breast block, 
and intercostal nerve block. TEB and TPVB are generally per-
formed. 
    TPVB is carried out by administering local anesthetics to 
the paravertebral space in the thoracic vertebra and inducing 
ipsilateral somatic and sympathetic nerve blockade of several 
levels of the thoracic dermatome [9]. The thoracic paravertebral 
space (TPVS) is a wedge-shaped space, its base formed by the 
posterolateral aspect of the vertebral body, intervertebral disc, 
and intervertebral foramen. The anterolateral wall is formed 
by the parietal pleura, and the posterior wall is formed by the 
superior costotransverse ligament. The lateral wall consists of 
the intercostal space and the intervertebral foramen, and the 
medial wall is consisted of the epidural space. The contralateral 
paravertebral space is connected to the prevertebral space. 
Techniques including the loss of resistance technique utilizing 
air in assessing the location, and also pressure measurement 
techniques and the methods using fluoroscopy [9] are known. 
Recently, it was performed using a nerve stimulator or 
ultrasonography [10].
    According to the direction of the accessed needle, the 
classical approach is to vertically come in 2.5 to 3 cm lateral to 
the midline. The medial approach is to come in 1 cm laterally, 
and paravertebral-peridural block is to approach 45° on the 
coronal plane [9], in concern with the frequency of injection, 
satisfactory results were obtained in more than 90% by a single 
injection [11], and it has been also reported that in comparison 
to single injection, success rate was noticeably high in multilevel 
injection [12].
    In a study conducted on patients undergoing thoracotomy, 
regarding postoperative pain control during the postoperative 
period, TPVB was superior to TEB. Pulmonary function tests 
utilizing the peak expiratory flow rate and oximetry similarly 
showed better results [13]. Complications may develop in both 
TEB and TPVB. However, TEB performed in the epidural space 
can result in catastrophic injuries such as spinal cord injury, 
and so TPVB may be a safer procedure.
    Hypotension or urinary retention due to the blocking of the 
sympathetic chain may occur in both TEB and TPVB, but the 
incidence is higher in TEB. Postoperative nausea, vomiting, 
and respiratory depression are more frequent in TEB than 
TPVB. In addition, the success rate of TPVB is higher [14]. When 
comparing bupivacaine with ropivacaine use in breast surgery, 
cases using ropivacaine showed better results regarding the 
satisfaction of the patient after surgery, and the continued 
analgesic period [15].
    The authors performed TPVB that is hemodynamically 
safer and produce fewer complications in comparison with 
TEB. To raise blockage success rates, multilevel injection was 
performed, and ropivacaine, which is known for its excellent 
effects in the aspect of longer analgesic time, was used.
    In summary, the authors performed TPVB in a woman 8 
weeks pregnant considering the risk/benefit ratio and the 
effects of anesthetics on the mother and the fetus. Without 
complications, the breast abscess was safely and successfully 
removed.
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